Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | ELANE | P08246 | 3/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MMP12 | P39900 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7042715 | 0.85 | OPRD1 (0.40) | BCHEABCB1ALDH1A1ELANEF2 | |
| SCHEMBL7176605 | 0.84 | ABCB1 (0.44) | BCHEABCB1ALDH1A1GAAMAPT | |
| SCHEMBL7042722 | 0.84 | ALDH1A1 (0.41) | ABCB1ALDH1A1ELANEF2GAA | |
| SCHEMBL7251318 | 0.83 | BCHE (0.48) | BCHEABCB1ALDH1A1GAAMAPT | |
| SCHEMBL7606264 | 0.80 | ALDH1A1 (0.46) | BCHEABCB1ALDH1A1ELANEF2 | |
| SCHEMBL7246404 | 0.80 | BCHE (0.44) | BCHEABCB1ALDH1A1MAPTMEN1 | |
| SCHEMBL7245922 | 0.79 | POLB (0.43) | BCHEABCB1ALDH1A1GAAMAPT | |
| SCHEMBL7245999 | 0.76 | CTSV (0.41) | BCHEABCB1ALDH1A1MAPTMEN1 | |
| SCHEMBL7037109 | 0.74 | BCHE (0.43) | BCHEABCB1ALDH1A1MAPTMEN1 | |
| SCHEMBL6539481 | 0.74 | RAB9A (0.45) | MAPTADRB3ADRB2ADRB1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030073846-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073846-A1 | Aminoalcohol derivatives | XDH, ADH1A, ADRB1 | BCHE 3174/4885ABCB1 2117/4885ALDH1A1 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.